Shopping Cart

Your shopping cart is currently empty

MS-444

Name: MS-444
Brand: TargetMol
SKU: T16145
Price: 799 USD
Availability: InStock
Rating: 5 (10 reviews)

Copy Product Info

😃Good

Catalog No. T16145Cas No. 150045-18-4

Alias MS444, BE-34776, BE34776

MS-444 (BE-34776) is a smooth muscle myosin light chain kinase (MLCK) and HuR inhibitor with antitumor activity for triple-negative breast and colorectal cancer.

MS-444

Copy Product Info

😃Good

Purity: 99.45%

Catalog No. T16145Alias MS444, BE-34776, BE34776Cas No. 150045-18-4

MS-444 (BE-34776) is a smooth muscle myosin light chain kinase (MLCK) and HuR inhibitor with antitumor activity for triple-negative breast and colorectal cancer.

Pack Size	Price	USA Warehouse	Global Warehouse	Quantity
2 mg	$799	-	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:99.45%

Appearance:Solid

Color:White

Resource Download

COA

Product Introduction

Bioactivity

Description	MS-444 (BE-34776) is a smooth muscle myosin light chain kinase (MLCK) and HuR inhibitor with antitumor activity for triple-negative breast and colorectal cancer.
Targets&IC50	RIE-1 cells:40.70 μM, SW480 cells:10.98 μM, YAMC cells:28.16 μM, HCA7 cells:12.84 μM, RKO cells:5.60 μM, HT29 cells:14.21 μM, HCT116 cells:10.98 μM
In vitro	MS-444 is a small molecule RNA-binding protein HuR (ELAVL1) inhibitor. Colorectal cancer (CRC) cells that show HuR overexpression are treated with MS-444 (1-100 μM) for 48 hr (HCT116 IC50=10.98 μM, HCA-7 IC50=12.84 μM, RKO IC50=5.60 μM, HT-29 IC50=14.21 μM, and SW480 IC50=10.98 μM). Contrasting effects are observed using non-transformed small intestinal (RIE-1 IC50=40.70 μM) and colonic epithelial cells (YAMC IC50=28.16 μM). [1]
In vivo	Mice bearing HCT116 cell xenografts receive intraperitoneal injections of MS-444 (25 mg/kg) or vehicle every 48 hr to test the effects of MS-444 on CRC cell growth in vivo. Anti-tumor effects of MS-444 are observed with an approximately 1.7-fold reduction in tumor size. Mice treated with MS-444 shows a marked 2- to 3-fold reduction in microvessel density (MVD), showing the anti-angiogenic potential of MS-444. [1]
Synonyms	MS444, BE-34776, BE34776

Chemical Properties

Molecular Weight	230.22
Formula	C₁₃H₁₀O₄
Cas No.	150045-18-4
Smiles	O=C1C=2C(O)=CC=C(O)C2CC3=COC(=C13)C
Relative Density.	1.452g/cm3

Storage & Solubility Information

Storage

keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 40 mg/mL (173.75 mM), Sonication is recommended.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	4.3437 mL	21.7184 mL	43.4367 mL	217.1836 mL
5 mM	0.8687 mL	4.3437 mL	8.6873 mL	43.4367 mL
10 mM	0.4344 mL	2.1718 mL	4.3437 mL	21.7184 mL
20 mM	0.2172 mL	1.0859 mL	2.1718 mL	10.8592 mL
50 mM	0.0869 mL	0.4344 mL	0.8687 mL	4.3437 mL
100 mM	0.0434 mL	0.2172 mL	0.4344 mL	2.1718 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc